Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.72 Million - $1.97 Million
-12,807 Reduced 66.15%
6,555 $880,000
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $734,065 - $933,236
-5,334 Reduced 21.6%
19,362 $2.97 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $1.68 Million - $2.08 Million
-12,718 Reduced 33.99%
24,696 $4 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $1.84 Million - $2.33 Million
-17,126 Reduced 31.4%
37,414 $5.07 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $2.23 Million - $2.53 Million
-20,948 Reduced 27.75%
54,540 $5.89 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $232,829 - $259,385
-2,213 Reduced 2.85%
75,488 $8.5 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $196,313 - $216,117
1,919 Added 2.53%
77,701 $8.41 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1.59 Million - $2.14 Million
19,735 Added 35.21%
75,782 $8.12 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $700,510 - $822,167
8,154 Added 17.03%
56,047 $4.91 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $246,156 - $329,393
3,355 Added 7.53%
47,893 $4.73 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $470,914 - $713,964
7,301 Added 19.61%
44,538 $3.37 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $240,265 - $300,622
-3,331 Reduced 8.21%
37,237 $3.3 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $19,523 - $23,473
310 Added 0.77%
40,568 $3.07 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $136,984 - $175,098
2,085 Added 5.46%
40,258 $2.93 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $415,090 - $488,540
-5,381 Reduced 12.35%
38,173 $3.07 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $30,595 - $37,731
-393 Reduced 0.89%
43,554 $3.89 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $311,985 - $346,829
-3,509 Reduced 7.39%
43,947 $4.15 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $26,844 - $31,762
-299 Reduced 0.63%
47,456 $4.4 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $18,954 - $25,381
206 Added 0.43%
47,755 $4.52 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $28,390 - $31,132
-317 Reduced 0.66%
47,549 $4.6 Million
Q3 2017

Nov 03, 2017

BUY
$69.85 - $89.22 $61,467 - $78,513
880 Added 1.87%
47,866 $4.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
46,986
46,986 $3.42 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brown Advisory Securities, LLC Portfolio

Follow Brown Advisory Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.